Embracing Future Holdings Ltd Ordinary Shares 8YY
Trading Information
- Previous Close Price
- SGD 0.03
- Day Range
- SGD 0.03–0.03
- 52-Week Range
- SGD 0.02–0.09
- Bid/Ask
- SGD 0.03 / SGD 0.03
- Shares Outstanding
- 1.73B
- Market Cap
- SGD 57.20M
- Volume/Avg
- 2M / 324,233
Key Statistics
- Price/Earnings (Normalized)
- 2,750.00
- Price/Sales
- 8.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 16
- Website
- https://www.ebfholdings.com
Valuation
|
Metric
|
8YY
|
|---|---|
Price/Earnings (Normalized) | 2,750.00 |
Price/Book Value | — |
Price/Sales | 8.39 |
Price/Cash Flow | 63.95 |
Price/Earnings
8YY
Financial Strength
|
Metric
|
8YY
|
|---|---|
Quick Ratio | 1.17 |
Current Ratio | 1.39 |
Interest Coverage | −35.46 |
Quick Ratio
8YY
Profitability
|
Metric
|
8YY
|
|---|---|
Return on Assets (Normalized) | −59.50% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −73.71% |
Return on Assets
8YY
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|?rKXp>M$ | LOCK|z> | $245B | |||
| Danaher Corp
DHR
| LOCK|@>R%nV^Z | LOCK|bDJ | $157B | |||
| Agilent Technologies Inc
A
| LOCK|P$trp%! | LOCK|!P | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|WnhSTDK | LOCK|YQJ$ | $43B | |||
| Waters Corp
WAT
| LOCK|pDb!<B | LOCK|N% | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|?d$Gc^& | LOCK|<! | $41B | |||
| Illumina Inc
ILMN
| LOCK|y>$R^?! | LOCK|tk&&p | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|S@@&#R%^ | LOCK|$wfl! | $32B | |||
| Quest Diagnostics Inc
DGX
| LOCK|>%>vB>@ | LOCK|F?&GY | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|><!%<y? | LOCK|yW?w | $25B |
United States